Back to HALO
VANGUARD CAPITAL MANAGEMENT LLC → HALO
VANGUARD CAPITAL MANAGEMENT LLC HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$563.8M
Q3 2026
Peak value
$563.8M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $340.7M |
| Q1 2026 | $340.7M |
| Q2 2026 | $418.8M |
| Q3 2026 | $563.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $563.8M | 5.11M | — | — |
| Q2 2026 | $418.8M | 5.35M | — | — |
| Q1 2026 | $340.7M | 5.27M | — | — |
| Q1 2026 | $340.7M | 5.27M | — | — |
Other funds holding HALO
$915.4M
$649.5M
$559M
$545.3M
$539.3M
$531.8M